Prosecution Insights
Last updated: September 26, 2026

QuidelOrtho

Technology area: Biotechnology & Pharmaceuticals

9 pending office actions • 6 art units • 9 examiners • 0 of 9 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days

Portfolio Summary

9
Total Pending OAs
5
Non-Final OAs
4
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
1
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

7
Hard (78%)
0
Medium (0%)
2
Easy (22%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 only2 (22%)
§101 + other4 (44%)
§112 only1 (11%)
Double-patenting only1 (11%)
Multi-statute (no §101)1 (11%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

8
Life Sciences
89% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
1
Semiconductors
11% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

90 h
Manual time on pending OAs
18 h
Time saved (low, 20%)
31 h
Time saved (mid, 35%)
0.8 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
LU, FRANK WEI MIN 1 62.6% +67.7%
SCHULTZHAUS, JANNA NICOLE 1 35.5% +36.5%
BAILEY, STEVEN WILLIAM 1 32.1% +14.6%
LEVERETT, MARY CHANG 1 60.8% +23.8%
ZHANG, KAIJIANG 1 77.1% +34.4%
KALLAL, ROBERT JAMES 1 60.0% +32.4%
CLOW, LORI A 1 64.1% +28.6%
POHNERT, STEVEN C 1 12.3% +18.4%
ROSSI, VY BUI 1 29.5% +36.4%

Hard Cases (8)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17691999 METHODS AND COMPOSITIONS FOR ANALYZING NUCLEIC ACID CLOW, LORI A 23d overdue
18429893 METHODS FOR NON-INVASIVE ASSESSMENT OF GENETIC VARIATIONS SCHULTZHAUS, JANNA NICOLE —
18317573 Methods and Processes for Assessment of Genetic Variations BAILEY, STEVEN WILLIAM —
18080620 METHODS AND PROCESSES FOR NON-INVASIVE ASSESSMENT OF GENETIC VARIATIONS LEVERETT, MARY CHANG —
17751017 Sequencing Adapter Manufacture and Use ZHANG, KAIJIANG —
17773671 APPLICATION OF MOSAICISM RATIO IN MULTIFETAL GESTATIONS AND PERSONALIZED RISK ASSESSMENT KALLAL, ROBERT JAMES —
17333569 METHODS FOR REDUCING GUANINE AND CYTOSINE (GC) BIAS IN NUCLEOTIDE SEQUENCE READ COUNTS POHNERT, STEVEN C —
17140426 Methods and Processes for Non-Invasive Assessment of Genetic Variations ROSSI, VY BUI —

Interview Candidates (9)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17691999 METHODS AND COMPOSITIONS FOR ANALYZING NUCLEIC ACID CLOW, LORI A 23d overdue
18800497 METHODS AND PROCESSES FOR NON-INVASIVE ASSESSMENT OF GENETIC VARIATIONS LU, FRANK WEI MIN 72d
18429893 METHODS FOR NON-INVASIVE ASSESSMENT OF GENETIC VARIATIONS SCHULTZHAUS, JANNA NICOLE —
18317573 Methods and Processes for Assessment of Genetic Variations BAILEY, STEVEN WILLIAM —
18080620 METHODS AND PROCESSES FOR NON-INVASIVE ASSESSMENT OF GENETIC VARIATIONS LEVERETT, MARY CHANG —
17751017 Sequencing Adapter Manufacture and Use ZHANG, KAIJIANG —
17773671 APPLICATION OF MOSAICISM RATIO IN MULTIFETAL GESTATIONS AND PERSONALIZED RISK ASSESSMENT KALLAL, ROBERT JAMES —
17333569 METHODS FOR REDUCING GUANINE AND CYTOSINE (GC) BIAS IN NUCLEOTIDE SEQUENCE READ COUNTS POHNERT, STEVEN C —

Top Art Units

Art UnitApps
1685 3
1683 2
1672 1
2857 1
1684 1
1687 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18800497 METHODS AND PROCESSES FOR NON-INVASIVE ASSESSMENT OF GENETIC VARIATIONS LU, FRANK WEI MIN 1683 §112 Non-Final OA 72d Pending Aug 12, 2024
18429893 METHODS FOR NON-INVASIVE ASSESSMENT OF GENETIC VARIATIONS SCHULTZHAUS, JANNA NICOLE 1685 §101§112DP Non-Final OA — Pending Feb 01, 2024
18317573 Methods and Processes for Assessment of Genetic Variations BAILEY, STEVEN WILLIAM 1672 §101§102§112DP Non-Final OA — Pending May 15, 2023
18080620 METHODS AND PROCESSES FOR NON-INVASIVE ASSESSMENT OF GENETIC VARIATIONS LEVERETT, MARY CHANG 2857 §101DP Non-Final OA — Pending Dec 13, 2022
17751017 Sequencing Adapter Manufacture and Use ZHANG, KAIJIANG 1684 §102§103§112Other Non-Final OA — Pending May 23, 2022
17773671 APPLICATION OF MOSAICISM RATIO IN MULTIFETAL GESTATIONS AND PERSONALIZED RISK ASSESSMENT KALLAL, ROBERT JAMES 1685 §101 Final Rejection — Pending May 02, 2022
17691999 METHODS AND COMPOSITIONS FOR ANALYZING NUCLEIC ACID CLOW, LORI A 1687 §101 Final Rejection 23d overdue Pending Mar 10, 2022
17333569 METHODS FOR REDUCING GUANINE AND CYTOSINE (GC) BIAS IN NUCLEOTIDE SEQUENCE READ COUNTS POHNERT, STEVEN C 1683 §101§103§112DP Final Rejection — Pending May 28, 2021
17140426 Methods and Processes for Non-Invasive Assessment of Genetic Variations ROSSI, VY BUI 1685 DP Final Rejection — Pending Jan 04, 2021

Managing QuidelOrtho's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month